Trademarkia Logo

Canada

C$
Trademark Search in Canada
THINC-IT

View On IC.GC.CA

THINC-IT
REGISTERED

on 9 Jul 2019

Last Applicant/ Owned by

H. LUNDBECK A/S

Ottiliavej 92500 Valby

DK

Serial Number

1821459 filed on 6th Feb 2017

Registration Number

TMA1038853 registered on 9th Jul 2019

Registration expiry Date

9th Jul 2029

Correspondent Address

SMART & BIGGAR LP

1100-150 York StreetToronto

ONTARIO

CA

M5H3S5

THINC-IT

Trademark usage description

pharmaceuticals and medical preparations and substances and vaccines for the prevention and treatment of disorders and diseases in, generated by or ac Read More

Classification Information

Class [005]
Pharmaceuticals and medical preparations and substances and vaccines for the prevention and treatment of disorders and diseases in, generated by or acting on the central nervous system, namely, dementia, Alzheimer's disease and disorder, dizziness, seizures, stroke, depression, cognitive impairment, cognitive disorders and diseases, mood disorders, psychosis, anxiety, apathy, epilepsy, Lennox-Gastaut syndrome (LGS), sclerosis, porphyria, Huntington's disease and disorder, insomnia, Parkinson's disease and disorder, falls, movement disorders and diseases, schizophrenia, bipolar disorder and disease, ADHD, cancer, pain, alcoholism and dependency; pharmaceutical preparations and substances for the prevention and treatment of disorders and diseases in, generated by or acting on the central nervous system, namely dementia, Alzheimer's disease and disorder, dizziness, seizures, stroke, depression, cognitive impairment, cognitive disorders and diseases, mood disorders, psychosis, anxiety, apathy, epilepsy, Lennox-Gastaut syndrome (LGS), sclerosis, porphyria, Huntington's disease and disorder, insomnia, Parkinson's disease and disorder, falls, movement disorders and diseases, schizophrenia, bipolar disorder and disease, ADHD, cancer, pain, alcoholism and dependency; central nervous system stimulants; pharmaceutical preparations and substances for the prevention and treatment of psychiatric and neurological disorders and diseases, namely dementia, Alzheimer's disease and disorder, dizziness, seizures, stroke, depression, cognitive impairment, cognitive disorders and diseases, mood disorders, psychosis, anxiety, apathy, epilepsy, Lennox-Gastaut syndrome (LGS), sclerosis, porphyria, Huntington's disease and disorder, insomnia, Parkinson's disease and disorder, falls, movement disorders and diseases, schizophrenia, bipolar disorder and disease, ADHD, cancer, pain, alcoholism and dependency; pharmaceutical preparations and substances for the prevention and treatment of dementia, Alzheimer's disease and disorder, dizziness, seizures, stroke, depression, cognitive impairment, cognitive disorders and diseases, mood disorders, psychosis, anxiety, apathy, epilepsy, Lennox-Gastaut syndrome (LGS), sclerosis, porphyria, Huntington's disease and disorder, insomnia, Parkinson's disease and disorder, falls, movement disorders and diseases, schizophrenia, bipolar disorder and disease, ADHD, cancer, pain, alcoholism and dependency; diagnostic reagents and agents for medical diagnostic use

Classification kind code

11

Mark Details

Serial Number

1821459

Mark Type

Trademark

Legal History

Show more

Action TakenStatus
Submitted for opposition 50
on 1st Feb 2019		Allowed
Submitted for opposition 51
on 1st Feb 2019		Allowance Notice Sent
Submitted for opposition 42
on 17th Oct 2018		Advertised
Submitted for opposition 26
on 27th Sept 2018		Approved
Submitted for opposition 27
on 9th Aug 2018		Approval Notice Sent
Submitted for opposition 22
on 5th Jan 2018		Search Recorded
Submitted for opposition 20
on 5th Jan 2018		Examiner's First Report
Submitted for opposition 31
on 7th Feb 2017		Formalized
Submitted for opposition 30
on 6th Feb 2017		Filed
Submitted for opposition 1
on 6th Feb 2017		Created